Nanotechnology-based ocular drug delivery — the liposomes, polymeric nanoparticles, nanomicelles, and dendrimers engineered to enhance corneal penetration, prolong precorneal residence time, and enable posterior segment targeting — represents the fastest-advancing technology platform in the global ophthalmic therapeutics landscape, with the Ocular Drug Delivery...